Jassy Touts Amazon Pharmacy’s ‘Resonance’ With Customers
PYMNTS
|
Summary
**Jassy Touts Amazon Pharmacy’s ‘Resonance’ With Customers** Amazon CEO Andy Jassy highlighted the growing success and customer satisfaction of Amazon Pharmacy during the company’s Q2 earnings call. Launched in November 2020, Amazon Pharmacy has expanded its offerings, including the RxPass program for Medicare beneficiaries, which provides unlimited access to 60 common generic medications for $5 a month for Prime members. The service, which allows users to manage prescriptions digitally and receive discounts, is expanding same-day delivery to more U.S. cities. E-commerce experts credit Amazon's competitive pricing as a major factor in disrupting traditional pharmacy models, although online pharmacy remains a small market segment. **Account Onboarding Gets Its AI Makeover** Garrett Laird, director of product management at Amount, discusses the crucial role of proactive anti-fraud measures for financial institutions (FIs) during the "What's Next in Payments" series. Laird emphasizes that waiting to address fraud until breaches occur can be costly. Leveraging AI and machine learning in the onboarding process can enhance both security and customer satisfaction, making onboarding seamless while preventing fraud. Amount’s technology enables FIs to verify identities and detect fraud in real-time, thus striking a balance between blocking fraudulent activities and
